242 JOURNAL OF CHEMICAL RESEARCH 2011
7.69 (1H, td, J = 8.4, 1.2 Hz), 7.46–7.39 (3H, m), 7.34 (2H, d, J =
8.0 Hz), 7.03 (2H, d, J = 8.6 Hz), 3.88 (3H, s), 2.48 (3H, s); 13C NMR
δ: 21.4, 55.4, 114.1, 118.8, 125.5, 125.6, 125.8, 128.8, 129.1, 129.3,
129.6, 129.8, 131.9, 135.3, 138.2, 148.4, 149.0, 156.2, 160.6; MS
(EI): m/z (%) = 325 (M+, 100), 310 (41), 281 (22).
NMR δ: 8.29 (1H, s), 8.17 (2H, d, J = 7.2 Hz), 7.83–7.71 (3H, m),
7.58–7.42 (4H, m), 7.23–7.15 (2H, m); 13C NMR δ: 114.1 (J =
6.0 Hz), 114.2 (J = 6.0 Hz), 119.4, 124.9, 125.1, 127.2, 127.7 (2C),
129.1 (2C), 129.9, 130.2, 130.5, 134.4 (J = 6.0 Hz), 139.2 (J =
35 Hz), 141.5 (J = 35 Hz), 146.1, 148.8, 150.1 (J = 6.0 Hz), 152.6
(J = 6.0 Hz), 156.9; HRMS (ESI): Calcd for C21H13F3N 336.1000
(M+H)+ found 336.0990.
9-(p-Tolyl)-1,2,3,4-tetrahydroacridine (2n): Yellow solid; m.p.
135–136 °C (lit.27 145–146 °C); 1H NMR δ: 8.01 (1H, d, J = 8.4 Hz),
7.62–7.55 (1H, m), 7.36–7.26 (4H, m), 7.10 (2H, d, J = 8.0 Hz), 3.20
(2H, t, J = 6.6 Hz), 2.61 (2 H, t, J = 6.4 Hz), 2.46 (3H, s), 2.00–1.92
(2H, m), 1.79 (2H, m). 13C NMR δ: 21.2, 22.7, 22.9, 27.9, 33.9, 125.0,
125.5, 126.5, 127.7, 128.0, 128.2, 128.6 (2C), 128.9 (2C), 133.6,
137.1, 145.5, 146.6, 158.5; MS (ESI): m/z = 274.4 (M+1)+.
2-(3,4-Dimethylphenyl)-4-(p-tolyl)quinoline (2e): Pale yellow
solid; m.p. 115–116 °C; IR: νmax 2917, 1589, 1543, 1494, 823, 761
1
cm−1; H NMR δ: 8.23 (1H, d, J = 8.4 Hz), 7.98 (1H, s), 7.88 (2H,
t, J = 8.4 Hz), 7.77 (1H, s), 7.69(1H, td, J = 8.4, 1.2 Hz), 7.48–7.39
(3H, m), 7.34 (2H, d, J = 7.6 Hz), 7.25 (1H, t, J = 7.6 Hz), 2.47 (3H,
s), 2.38 (3H, s), 2.33 (3H, s); 13C NMR δ: 19.8, 20.1, 21.4, 29.8, 119.2,
124.9, 125.5, 125.6, 125.9, 128.6, 129.1 (2C), 129.3 (3C), 129.7,
130.0, 135.3, 136.9, 138.0, 138.1, 148.4, 149.0, 156.8; HRMS (ESI):
Calcd for C24H22N 324.1752 (M+H) found 324.1740.
2-(3,4-Dimethoxyphenyl)-4-(p-tolyl)quinoline (2f): Pale yellow
solid; m.p. 120–121 °C; IR: νmax 2930, 1590, 1517, 1498, 1263, 1024,
765 cm−1; 1H NMR δ: 8.22 (1H, d, J = 8.4 Hz), 7.88 (2H, m), 7.75 (1H,
s), 7.73–7.65 (2H, m), 7.46–7.41 (3H, m), 7.35 (2H, d, J = 8.0 Hz),
We are grateful to the National Natural Science Foundation of
China (No. 20876147) for financial support.
6.97 (1H, d, J = 8.4 Hz), 4.04 (3H, s), 3.95 (3H, s), 2.48 (3H, s); 13
C
Received 16 February 2011; 31 March 2011
Paper 1100576 doi: 10.3184/174751911X13026226423986
Published online: 3 May 2011
NMR δ: 21.4, 56.0, 56.1, 110.3, 110.9, 118.8, 120.2, 125.5, 125.8,
129.1 (2C), 129.3 (2C), 129.5, 129.6, 132.2, 135.3, 136.5, 138.2,
148.4, 149.0, 149.1, 150.1, 156.1; HRMS(ESI): Calcd for C24H22NO2
356.1651 (M+H) found 356.1644.
2-(4-Chlorophenyl)-4-(p-tolyl)quinoline (2g): white solid; m.p.
91–92 °C; IR: νmax 2917, 1592, 1491, 1091, 814, 756 cm−1; 1H NMR δ:
8.19 (1H, dd, J = 8.4, 0.4 Hz), 8.13–8.07 (2H, m), 7.89 (1H, dd,
J = 8.4, 0.8 Hz), 7.72 (1H, s), 7.69 (1H, td, J = 8.4, 1.6 Hz), 7.47–7.38
(5H, m), 7.32 (2H, d, J = 8.0 Hz), 2.46 (3H, s); 13C NMR δ: 30.1,
119.1, 125.9, 126.1, 126.6, 129.0 (2C), 129.2 (2C), 129.5 (2C), 129.6
(2C), 129.8, 130.2, 135.4, 135.7, 138.2, 138.6, 148.9, 149.6, 155.6;
HRMS (ESI): Calcd for C22H1735ClN 330.1050 (M+H) found
330.1033.
References
1
2
3
4
5
6
M.E. Doyle and J.M. Egan, Pharmacol. Rev., 2003, 55, 105.
R. Benigni, Chem. Rev., 2005, 105, 1767.
J.P. Michael, Nat. Prod. Rep., 2005, 22, 627.
R.G. Ridley, Nature, 2002, 415, 686.
P.L. Olliaro and W.R.J. Taylor, J. Exp. Biol., 2003, 206, 3753.
R. Klingenstein, P. Melnyk, S.R. Leliveld, A. Rycke-Busch and C. Korth,
J. Med. Chem., 2006, 49, 5300.
7
8
9
B. Lal, N.B. Bhise, R.M. Gidwani, A.D. Lakdawala, K. Joshi and
S. Parvardhan, ARKIVOC, 2005, ii, 77.
Y.L. Chen, Y.L. Zhao, C.M. Lu, C.C. Tzeng and J.P. Wang, Bioorg. Med.
Chem., 2006, 14, 4373.
M. Ishiwara, Y. Aoki, H. Takagaki, M. Ui and F. Okajima, J. Pharmacol.
2-(Furan-2-yl)-4-phenylquinoline (2h): White solid; m.p. 91–92 °C
1
(lit.26 90–92 °C); H NMR δ: 8.19 (1H, d, J = 8.4 Hz), 7.84 (1H, dd,
J = 8.4, 1.2 Hz), 7.76 (1H, s), 7.69 (1H, ddd, J = 8.4, 6.8, 1.2 Hz),
7.60 (1H, dd, J = 1.6, 0.8 Hz), 7.56–7.46 (6H, m), 7.43 (1H, td,
J = 8.4, 1.2 Hz), 6.57 (1H, dd, J = 3.6, 2.0 Hz); 13C NMR δ: 110.5,
112.2, 115.3, 117.6, 120.2, 125.6, 126.2, 128.4, 128.5 (2C), 129.3
(3C), 129.4, 129.7, 137.8, 144.1, 148.2, 149.2; MS (EI): m/z (%) = 271
(M+, 23), 195 (13), 183 (100), 77 (75).
2-(Thiophen-2-yl)-4-(p-tolyl)quinoline (2i): White solid; m.p.
95–96 °C; IR: νmax 2923, 1592, 1547, 1498, 1428, 1082, 821 cm−1; 1H
NMR δ: 8.13 (1H, d, J = 8.4 Hz), 7.84 (1H, d, J = 8.4 Hz), 7.77–7.59
(3H, m), 7.57–7.28 (5H, m), 7.13 (1H, dd, J = 4.8, 3.6 Hz), 2.47 (3H,
s); 13C NMR δ: 21.1, 117.5, 125.3, 125.4, 125.6, 127.6, 128.0, 128.3,
128.9 (2C), 129.0 (2C), 129.1, 129.2, 134.8, 137.9, 145.0, 148.2,
148.7, 151.4. HRMS (ESI): Calcd for C20H16NS 302.1003 (M+H)+
found 302.1004.
Exp. Ther., 2003, 307, 583.
10 P. Benedetti, R. Mannhold, G. Cruciani and G. Ottaviani, Bioorg. Med.
Chem., 2004, 12, 3607.
11 P.C. Appelbaum and M.R. Jacobs, Curr. Opin. Microbiol., 2005, 8, 510.
12 P. Narender, U. Srinivas, M. Ravinder, B.A. Rao, C. Ramesh,
K. Harakishore, B. Gan-gadasu, U.S.N. Murthy and V.J. Rao, Bioorg. Med.
Chem., 2006, 14, 4600.
13 T. Staalhandske and T. Kalland, Immunopharmacology, 1986, 11, 87.
14 T.H. Thatcher, I. Luzina, R. Fishelevich, M.A. Tomai, R.L. Miller and
A.A. Gaspari, J. Invest. Dermatol., 2006, 126, 821.
15 V. Bonnet, F. Mongin and F. Trecourt, Tetrahedron, 2002, 58, 4429.
16 J. Quintin, X. Franck and R. Hocquemiller, Tetrahedron Lett., 2002, 43,
3547.
17 A. Furstner, A. Leitner and M. Mendze, J. Am. Chem. Soc., 2002, 124,
13856.
18 T.J. Korn, M.A. Schade and M.N. Cheemala, Synthesis, 2006, 21, 3547.
19 T.J. Korn, G. Cahiez and P. Knochel, Synlett, 2003, 12, 1892.
20 M. Rueping and W. Ieawsuwan, Synlett, 2007, 2, 0247.
21 D.F. Aycock, Org. Process Res. Dev., 2007, 11, 156.
22 K.H. Kumar and P.T. Perumal, J. Heterocyclic Chem., 2008, 45, 597.
23 R. Martinez, D.J. Ramon and M. Yus, Eur. J. Org. Chem., 2007, 1599.
24 M. Shingo, I. Kunio and K. Isao, Nippon Kagaku Kaishi, 1979, 11, 1514.
25 J. Horn, S.P. Marsden and A. Nelson, Org. Lett., 2008, 10, 4117.
26 R.S. Hou, J.L. Wu and H.T. Cheng, J. Chi. Chem. Soc., 2008, 55,
915–918.
4-(Naphthalen-1-yl)-2-(p-tolyl)quinoline (2j): White solid; m.p.
1
135–136 °C; IR: νmax 2919, 1594, 1542, 782, 767 cm−1; H NMR δ:
8.33 (1H, s), 8.11 (2H, d, J = 8.0 Hz), 7.98 (2H, dd, J =15.6, 8.0 Hz),
7.90 (1H, s), 7.71 (1H, t, J = 7.6 Hz), 7.62 (1H, t, J = 7.2 Hz), 7.54–
7.46 (2H, m), 7.45–7.37 (2H, m), 7.33–7.26(4H, m), 2.43 (3H, s); 13
C
NMR δ: 21.5, 120.3, 125.2, 125.9, 126.0 (2C), 126.1, 126.4, 126.8,
127.3, 127.4 (2C), 128.2, 128.6, 129.5 (4C), 129.6, 131.8, 133.3,
135.8, 136.2, 139.5, 147.9, 156.5; HRMS (ESI): Calcd for C26 H20N
346.1596 (M+H)+ found 346.1596.
2-Phenyl-4-(3,4,5-trifluorophenyl)quinoline (2k): Pale yellow
solid; m.p. 146–147 °C; IR: νmax 3060, 1527, 1405, 1043, 772 cm−1; 1H
27 Y.K. Agrawal and H.M. Joshipura, Indian J. Chem., 2005, 44B, 1649.